Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer.
Lim S, Kim Y, Lee SB, Kang HG, Kim DH, Park JW, Chung D, Kong H, Yoo KH, Kim Y, Han W, Chun KH, Park JH.
Lim S, et al. Among authors: kim dh, kim y.
Oncogenesis. 2020 Oct 11;9(10):91. doi: 10.1038/s41389-020-00275-x.
Oncogenesis. 2020.
PMID: 33041328
Free PMC article.